BridgeMD
Esmolol versus Sufentanil on the quality of recovery after laparoscopic cholecystectomy during anesthesia with oro-tracheal intubation on ambulatory
EU CTIS ID: 2024-520282-31-00
What this study is testing
To evaluate whether the use of Esmolol is equivalent to the use of Sufentanil for patient comfort, assessed on the quality of recovery, after anesthesia with oro-tracheal intubation for laparoscopic cholecystectomy by a randomized trial.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult patient - ASA I to III - Planned outpatient cholecystectomy - General anesthesia with orotracheal intubation - Patient having signed their consent - Patient affiliated to a social security system
You likely can't join if
- - Patient on Beta-blockers - Uncontrolled high blood pressure - Contraindication to beta-blockers: in particular conduction disorders with BAV2 or 3, bradycardia with HR < 50 bpm - Hypersensitivity to the active substance or to any of the excipients of sufentanil and Esmolol - Pre-existing hemodynamic abnormality: HR < 50bpm and/or SBP < 90 mmHg and/or DBP < 50 mmHg and/or HR > 100 and/or SBP > 180 mmHg and/or DBP > 110 mmHg - Difficult expected intubation during anesthesia consultation - Severe obesity (BMI > 35 kg/m2) - Pregnant or breastfeeding woman - Patients deprived of liberty - Patient under guardianship/curatorship
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.